ViiV and Axmed expand access to HIV medicines Agreement enables procurement in over 50 countries Read More
Osivax reports phase 2b data for OVX836 Results support combination strategy for influenza vaccines Read More
Merz completes phase 3 recruitment for XEOMIN Global trials assess migraine prevention potential Read More
CHMP backs TALVEY plus daratumumab for earlier myeloma use Recommendation supports second-line combination option Read More